-transparent.png){kind=logo}
Protective effect of picroliv, active constituent of Picrorhiza kurrooa, against oxytetracycline induced hepatic damage. 1997
ICMR Centre for Advanced Pharmacological Research on Traditional Remedies, Central Drug Reserach Institute, Lucknow, India.
Picroliv, the active constituent of P. kurrooa, showed a dose dependent (1.5-12 mg/kg, po for 7 days) hepatoprotective activity against oxytetracycline induced hepatic damage in rat. It increased the number of viable hepatocytes (ex-vivo) significantly. Increase in bile volume and its contents in conscious rat suggests potent anticholestatic property. Picroliv also antagonised alterations in enzyme levels (GOT, GPT, and alkaline phosphatase) in isolated hepatocytes and serum, induced by oxytetracycline (200 mg/kg, i.p.) feeding. Picroliv was more potent than silymarin a known hepatoprotective drug.
Related Publications
B Saraswat, and
P K Visen, and
G K Patnaik, and
B N Dhawan
January 2001,
Teratogenesis, carcinogenesis, and mutagenesis,
B Saraswat, and
P K Visen, and
G K Patnaik, and
B N Dhawan
August 1991,
Journal of ethnopharmacology,
B Saraswat, and
P K Visen, and
G K Patnaik, and
B N Dhawan
July 1992,
Biochemical pharmacology,
B Saraswat, and
P K Visen, and
G K Patnaik, and
B N Dhawan
January 1998,
Life sciences,
B Saraswat, and
P K Visen, and
G K Patnaik, and
B N Dhawan
May 1991,
Pharmacological research,
B Saraswat, and
P K Visen, and
G K Patnaik, and
B N Dhawan
January 2007,
Drug and chemical toxicology,
B Saraswat, and
P K Visen, and
G K Patnaik, and
B N Dhawan
January 1998,
Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology,
B Saraswat, and
P K Visen, and
G K Patnaik, and
B N Dhawan
February 1991,
Planta medica,
B Saraswat, and
P K Visen, and
G K Patnaik, and
B N Dhawan
August 2016,
Indian journal of experimental biology,
B Saraswat, and
P K Visen, and
G K Patnaik, and
B N Dhawan
February 1991,
Planta medica,
